443 related articles for article (PubMed ID: 16557281)
1. Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
Kondo T; Ezzat S; Asa SL
Nat Rev Cancer; 2006 Apr; 6(4):292-306. PubMed ID: 16557281
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis and mechanisms of thyroid cancer.
Xing M
Nat Rev Cancer; 2013 Mar; 13(3):184-99. PubMed ID: 23429735
[TBL] [Abstract][Full Text] [Related]
3. Integrated genomic characterization of papillary thyroid carcinoma.
Cancer Genome Atlas Research Network
Cell; 2014 Oct; 159(3):676-90. PubMed ID: 25417114
[TBL] [Abstract][Full Text] [Related]
4. RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
Santoro M; Melillo RM; Fusco A
Eur J Endocrinol; 2006 Nov; 155(5):645-53. PubMed ID: 17062879
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for the management of thyroid cancer.
Perros P; Boelaert K; Colley S; Evans C; Evans RM; Gerrard Ba G; Gilbert J; Harrison B; Johnson SJ; Giles TE; Moss L; Lewington V; Newbold K; Taylor J; Thakker RV; Watkinson J; Williams GR;
Clin Endocrinol (Oxf); 2014 Jul; 81 Suppl 1():1-122. PubMed ID: 24989897
[No Abstract] [Full Text] [Related]
6. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
7. The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations.
Jung CK; Little MP; Lubin JH; Brenner AV; Wells SA; Sigurdson AJ; Nikiforov YE
J Clin Endocrinol Metab; 2014 Feb; 99(2):E276-85. PubMed ID: 24248188
[TBL] [Abstract][Full Text] [Related]
8. Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System for Differentiated and Anaplastic Thyroid Cancer (Eighth Edition): What Changed and Why?
Tuttle RM; Haugen B; Perrier ND
Thyroid; 2017 Jun; 27(6):751-756. PubMed ID: 28463585
[No Abstract] [Full Text] [Related]
9. Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer.
Vaisman F; Shaha A; Fish S; Michael Tuttle R
Clin Endocrinol (Oxf); 2011 Jul; 75(1):112-9. PubMed ID: 21521273
[TBL] [Abstract][Full Text] [Related]
10. Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Nikiforov YE; Seethala RR; Tallini G; Baloch ZW; Basolo F; Thompson LD; Barletta JA; Wenig BM; Al Ghuzlan A; Kakudo K; Giordano TJ; Alves VA; Khanafshar E; Asa SL; El-Naggar AK; Gooding WE; Hodak SP; Lloyd RV; Maytal G; Mete O; Nikiforova MN; Nosé V; Papotti M; Poller DN; Sadow PM; Tischler AS; Tuttle RM; Wall KB; LiVolsi VA; Randolph GW; Ghossein RA
JAMA Oncol; 2016 Aug; 2(8):1023-9. PubMed ID: 27078145
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology of thyroid cancer: diagnostic and clinical implications.
Fagin JA; Mitsiades N
Best Pract Res Clin Endocrinol Metab; 2008 Dec; 22(6):955-69. PubMed ID: 19041825
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics and diagnosis of thyroid cancer.
Nikiforov YE; Nikiforova MN
Nat Rev Endocrinol; 2011 Aug; 7(10):569-80. PubMed ID: 21878896
[TBL] [Abstract][Full Text] [Related]
13. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.
Tuttle RM; Tala H; Shah J; Leboeuf R; Ghossein R; Gonen M; Brokhin M; Omry G; Fagin JA; Shaha A
Thyroid; 2010 Dec; 20(12):1341-9. PubMed ID: 21034228
[TBL] [Abstract][Full Text] [Related]
14. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
Pacini F; Schlumberger M; Dralle H; Elisei R; Smit JW; Wiersinga W;
Eur J Endocrinol; 2006 Jun; 154(6):787-803. PubMed ID: 16728537
[No Abstract] [Full Text] [Related]
15. The role of BRAF in the pathogenesis of thyroid carcinoma.
Li DD; Zhang YF; Xu HX; Zhang XP
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1068-78. PubMed ID: 25961545
[TBL] [Abstract][Full Text] [Related]
16. BRAFV600E mutation, TIMP-1 upregulation, and NF-κB activation: closing the loop on the papillary thyroid cancer trilogy.
Bommarito A; Richiusa P; Carissimi E; Pizzolanti G; Rodolico V; Zito G; Criscimanna A; Di Blasi F; Pitrone M; Zerilli M; Amato MC; Spinelli G; Carina V; Modica G; Latteri MA; Galluzzo A; Giordano C
Endocr Relat Cancer; 2011 Dec; 18(6):669-85. PubMed ID: 21903858
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.
Gruber JJ; Colevas AD
Oncologist; 2015 Feb; 20(2):113-26. PubMed ID: 25616432
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs as a potential tool in the differential diagnosis of thyroid cancer: a systematic review and meta-analysis.
Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
Clin Endocrinol (Oxf); 2016 Jan; 84(1):127-33. PubMed ID: 25510178
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutation in papillary thyroid cancer: A cost-utility analysis of preoperative testing.
Lee WS; Palmer BJ; Garcia A; Chong VE; Liu TH
Surgery; 2014 Dec; 156(6):1569-77; discussion 1577-8. PubMed ID: 25444226
[TBL] [Abstract][Full Text] [Related]
20. Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Nikiforov YE; Carty SE; Chiosea SI; Coyne C; Duvvuri U; Ferris RL; Gooding WE; Hodak SP; LeBeau SO; Ohori NP; Seethala RR; Tublin ME; Yip L; Nikiforova MN
Cancer; 2014 Dec; 120(23):3627-34. PubMed ID: 25209362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
